ERBB2 and breast carcinoma: Similar to breast carcinoma, conventional immunohistochemistry has identified that SDC often exhibits overexpression of androgen receptor (AR), HER2 (coded by ERBB2 gene) and epidermal growth factor receptor (EGFR)8,12–17.